https://bristolmyers2016ir.q4web.com/generated by Q4Wed, 20 May 2026 01:29:58 -0400Copyright Q4 Inc. All rights reserved.2feb3a72-cc87-4abe-a115-596622a1f3dahttps://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-and-Hengrui-Pharma-Announce-Strategic-Agreements-to-Advance-Innovative-Medicines-Across-Oncology-Hematology-and-Immunology-2026-vNsoGgwkDc/default.aspxTue, 12 May 2026 00:00:00 -04003edac111-3786-40c5-ae3a-1b09e8c6d8fehttps://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Receives-European-Commission-Approval-of-Sotyktu-deucravacitinib-for-the-Treatment-of-Active-Psoriatic-Arthritis-in-Adults/default.aspxFri, 08 May 2026 06:59:00 -04000ff15ead-89b8-4621-9268-e36b8d166f19https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-to-Participate-in-the-Bank-of-America-Securities-Healthcare-Conference-2026/default.aspxWed, 06 May 2026 06:59:00 -0400a4d22125-8589-4644-9006-5bdc56c3c590https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Launches-Wont-Lose-Media-Campaign-Ahead-of-FIFA-World-Cup-2026/default.aspxMon, 04 May 2026 06:59:00 -04000e137dad-4690-49ba-bdbd-de2bcf914412https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Reports-First-Quarter-Financial-Results-for-2026/default.aspxThu, 30 Apr 2026 06:59:00 -0400fa4c9d78-2463-48df-b914-9129e01b77e0https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-and-Pfizer-to-Make-Eliquis-apixaban-Available-via-Mark-Cuban-Cost-Plus-Drug-Company/default.aspxFri, 24 Apr 2026 06:59:00 -0400b4dc8842-1969-45f0-aa28-90025cb28df9https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Evolves-and-Expands-Standing-in-the-Gaap-to-Advance-More-Equitable-Care-in-Multiple-Myeloma-as-Program-Marks-Ten-Years/default.aspxTue, 31 Mar 2026 06:59:00 -0400b1eacdbf-80e8-4d5a-a0f0-c0572bc49302https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Presents-Positive-Results-from-Phase-3-SCOUT-HCM-Trial-Demonstrating-Efficacy-and-Safety-of-Camzyos-mavacamten-in-Adolescents-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-oHCM/default.aspxSun, 29 Mar 2026 11:45:00 -0400df08cb23-9fa6-4afd-9cf9-70f6d3d2efc7https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Open-Label-Outpatient-Switch-Study-Demonstrates-Symptom-Stability-During-Transition-from-Oral-Atypical-Antipsychotics-to-Cobenfy-xanomeline-and-trospium-chloride/default.aspxSat, 28 Mar 2026 07:00:00 -0400a81171e5-8020-41dd-a39e-13708e2ed459https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Reinforces-Leadership-in-oHCM-with-New-Camzyos-mavacamten-Data-at-American-College-of-Cardiology-Annual-Scientific-Session--Expo-2026-ACC-26/default.aspxMon, 23 Mar 2026 06:59:00 -0400